ELECTROCORE INC (ECOR) Stock Fundamental Analysis

NASDAQ:ECOR • US28531P2020

6.66 USD
+0.41 (+6.56%)
Last: Feb 23, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, ECOR scores 2 out of 10 in our fundamental rating. ECOR was compared to 185 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ECOR have multiple concerns. ECOR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ECOR has reported negative net income.
  • In the past year ECOR has reported a negative cash flow from operations.
  • ECOR had negative earnings in each of the past 5 years.
  • ECOR had a negative operating cash flow in each of the past 5 years.
ECOR Yearly Net Income VS EBIT VS OCF VS FCFECOR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

  • ECOR's Return On Assets of -66.13% is on the low side compared to the rest of the industry. ECOR is outperformed by 71.35% of its industry peers.
Industry RankSector Rank
ROA -66.13%
ROE N/A
ROIC N/A
ROA(3y)-88.18%
ROA(5y)-75.86%
ROE(3y)-180.1%
ROE(5y)-137.89%
ROIC(3y)N/A
ROIC(5y)N/A
ECOR Yearly ROA, ROE, ROICECOR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

  • ECOR has a Gross Margin of 86.04%. This is amongst the best in the industry. ECOR outperforms 95.14% of its industry peers.
  • In the last couple of years the Gross Margin of ECOR has grown nicely.
  • The Profit Margin and Operating Margin are not available for ECOR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 86.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.4%
GM growth 5Y10.55%
ECOR Yearly Profit, Operating, Gross MarginsECOR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • ECOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ECOR has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ECOR has been increased compared to 5 years ago.
  • ECOR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ECOR Yearly Shares OutstandingECOR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ECOR Yearly Total Debt VS Total AssetsECOR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • ECOR has an Altman-Z score of -11.32. This is a bad value and indicates that ECOR is not financially healthy and even has some risk of bankruptcy.
  • ECOR has a worse Altman-Z score (-11.32) than 78.92% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -11.32
ROIC/WACCN/A
WACC9.91%
ECOR Yearly LT Debt VS Equity VS FCFECOR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

  • ECOR has a Current Ratio of 1.43. This is a normal value and indicates that ECOR is financially healthy and should not expect problems in meeting its short term obligations.
  • ECOR's Current ratio of 1.43 is on the low side compared to the rest of the industry. ECOR is outperformed by 76.76% of its industry peers.
  • ECOR has a Quick Ratio of 1.33. This is a normal value and indicates that ECOR is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.33, ECOR is not doing good in the industry: 63.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.33
ECOR Yearly Current Assets VS Current LiabilitesECOR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.04% over the past year.
  • ECOR shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.90%.
  • ECOR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 60.15% yearly.
EPS 1Y (TTM)6.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.03%
Revenue 1Y (TTM)27.9%
Revenue growth 3Y66.56%
Revenue growth 5Y60.15%
Sales Q2Q%32.58%

3.2 Future

  • Based on estimates for the next years, ECOR will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.13% on average per year.
  • ECOR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 28.95% yearly.
EPS Next Y-9.59%
EPS Next 2Y5.16%
EPS Next 3Y17.13%
EPS Next 5YN/A
Revenue Next Year26.73%
Revenue Next 2Y29.59%
Revenue Next 3Y30.04%
Revenue Next 5Y28.95%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ECOR Yearly Revenue VS EstimatesECOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M 100M
ECOR Yearly EPS VS EstimatesECOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15 -20 -25

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ECOR. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ECOR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ECOR Price Earnings VS Forward Price EarningsECOR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECOR Per share dataECOR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ECOR's earnings are expected to grow with 17.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.16%
EPS Next 3Y17.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ECOR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ELECTROCORE INC

NASDAQ:ECOR (2/23/2026, 8:00:02 PM)

6.66

+0.41 (+6.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)03-10
Inst Owners8.99%
Inst Owner Change28.46%
Ins Owners26.79%
Ins Owner Change2.24%
Market Cap53.28M
Revenue(TTM)29.84M
Net Income(TTM)-14.16M
Analysts83.64
Price Target20.07 (201.35%)
Short Float %5.33%
Short Ratio4.29
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-19.76%
Min EPS beat(2)-40.66%
Max EPS beat(2)1.14%
EPS beat(4)2
Avg EPS beat(4)-16.52%
Min EPS beat(4)-40.66%
Max EPS beat(4)1.19%
EPS beat(8)6
Avg EPS beat(8)-2.82%
EPS beat(12)7
Avg EPS beat(12)-4.35%
EPS beat(16)7
Avg EPS beat(16)-5.59%
Revenue beat(2)2
Avg Revenue beat(2)4.43%
Min Revenue beat(2)0.24%
Max Revenue beat(2)8.61%
Revenue beat(4)2
Avg Revenue beat(4)0.93%
Min Revenue beat(4)-3.11%
Max Revenue beat(4)8.61%
Revenue beat(8)5
Avg Revenue beat(8)3.18%
Revenue beat(12)7
Avg Revenue beat(12)3.29%
Revenue beat(16)9
Avg Revenue beat(16)2.01%
PT rev (1m)-2.09%
PT rev (3m)-6.64%
EPS NQ rev (1m)0.61%
EPS NQ rev (3m)-3.82%
EPS NY rev (1m)-0.87%
EPS NY rev (3m)-5.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.79
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.71
EYN/A
EPS(NY)-1.44
Fwd EYN/A
FCF(TTM)-1
FCFYN/A
OCF(TTM)-0.99
OCFYN/A
SpS3.73
BVpS-0.13
TBVpS-0.13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -66.13%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 86.04%
FCFM N/A
ROA(3y)-88.18%
ROA(5y)-75.86%
ROE(3y)-180.1%
ROE(5y)-137.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.4%
GM growth 5Y10.55%
F-Score3
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 1.33
Altman-Z -11.32
F-Score3
WACC9.91%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.03%
EPS Next Y-9.59%
EPS Next 2Y5.16%
EPS Next 3Y17.13%
EPS Next 5YN/A
Revenue 1Y (TTM)27.9%
Revenue growth 3Y66.56%
Revenue growth 5Y60.15%
Sales Q2Q%32.58%
Revenue Next Year26.73%
Revenue Next 2Y29.59%
Revenue Next 3Y30.04%
Revenue Next 5Y28.95%
EBIT growth 1Y-1.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-4.75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.25%
OCF growth 3YN/A
OCF growth 5YN/A

ELECTROCORE INC / ECOR FAQ

What is the fundamental rating for ECOR stock?

ChartMill assigns a fundamental rating of 2 / 10 to ECOR.


Can you provide the valuation status for ELECTROCORE INC?

ChartMill assigns a valuation rating of 0 / 10 to ELECTROCORE INC (ECOR). This can be considered as Overvalued.


Can you provide the profitability details for ELECTROCORE INC?

ELECTROCORE INC (ECOR) has a profitability rating of 1 / 10.


What is the financial health of ELECTROCORE INC (ECOR) stock?

The financial health rating of ELECTROCORE INC (ECOR) is 1 / 10.


Can you provide the expected EPS growth for ECOR stock?

The Earnings per Share (EPS) of ELECTROCORE INC (ECOR) is expected to decline by -9.59% in the next year.